Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Conrad

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Neuroimage|February 22, 2003
Differential modulation of subcortical target and cortex during deep brain stimulationB Haslinger, H Boecker, C Büchel, et al.
AJNR. American Journal of Neuroradiology|May 9, 2020
Comparison of MRI, MRA, and DSA for Detection of Cerebral Arteriovenous Malformations in Hereditary Hemorrhagic TelangiectasiaM Vella, M D Alexander, M C Mabray, et al.
Journal of Animal Science|April 29, 2026
Clodronate disodium reduced TRAP5b independent of affecting other systemic biomarkers of bone resorption or formation in yearling, exercising Quarter HorsesBrittany L Paris, Jessica L Leatherwood, Carolyn E Arnold, et al.
Journal of Animal Science|April 22, 2025
Effects of clodronate disodium on endocrine regulators of calcium in yearling horsesMatthew B Conrad, Jessica L Leatherwood, Brittany L Paris, et al.
Journal of Animal Science|November 12, 2025
Effects of clodronate disodium on markers of inflammation and cartilage metabolism in juvenile horses challenged with intra-articular lipopolysaccharideJames M George, Jessica L Leatherwood, Brittany L Paris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patientsV Möbus, G von Minckwitz, C Jackisch, et al.
International Journal of Molecular Sciences|June 28, 2023
Stability Characterization of the Novel Anti-Cancer HM-10/10 HDL-Mimetic PeptideMichael P Dempsey, Katelyn E Andersen, Brittney M Wells, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2025
Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scaleHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.
Gynecologic Oncology|September 26, 2022
Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry studyGretchen E Glaser, Olivia D Lara, Bhavana Pothuri, et al.
The New England Journal of Medicine|September 18, 2024
Pomalidomide for Epistaxis in Hereditary Hemorrhagic TelangiectasiaHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Neuroimage|February 22, 2003
Differential modulation of subcortical target and cortex during deep brain stimulationB Haslinger, H Boecker, C Büchel, et al.
AJNR. American Journal of Neuroradiology|May 9, 2020
Comparison of MRI, MRA, and DSA for Detection of Cerebral Arteriovenous Malformations in Hereditary Hemorrhagic TelangiectasiaM Vella, M D Alexander, M C Mabray, et al.
Journal of Animal Science|April 29, 2026
Clodronate disodium reduced TRAP5b independent of affecting other systemic biomarkers of bone resorption or formation in yearling, exercising Quarter HorsesBrittany L Paris, Jessica L Leatherwood, Carolyn E Arnold, et al.
Journal of Animal Science|April 22, 2025
Effects of clodronate disodium on endocrine regulators of calcium in yearling horsesMatthew B Conrad, Jessica L Leatherwood, Brittany L Paris, et al.
Journal of Animal Science|November 12, 2025
Effects of clodronate disodium on markers of inflammation and cartilage metabolism in juvenile horses challenged with intra-articular lipopolysaccharideJames M George, Jessica L Leatherwood, Brittany L Paris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patientsV Möbus, G von Minckwitz, C Jackisch, et al.
International Journal of Molecular Sciences|June 28, 2023
Stability Characterization of the Novel Anti-Cancer HM-10/10 HDL-Mimetic PeptideMichael P Dempsey, Katelyn E Andersen, Brittney M Wells, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2025
Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scaleHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.
Gynecologic Oncology|September 26, 2022
Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry studyGretchen E Glaser, Olivia D Lara, Bhavana Pothuri, et al.
The New England Journal of Medicine|September 18, 2024
Pomalidomide for Epistaxis in Hereditary Hemorrhagic TelangiectasiaHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.
Pageof 29